Answers are grounded in this paper and cite their sources.
This analysis shows the effectiveness of a molecular diagnostic test to detect H. pylori infection in patients on acid-reducing medications, suggesting clinical benefits.
The Smart Gene molecular diagnostic test using intragastric fluid was useful for patients requiring PPI/P-CAB to manage gastrointestinal symptoms. It could also confirm an H. pylori infection and CAM-resistance mutations within 1 h of testing. This diagnostic test may help reduce side effects and the emergence of resistant strains due to unnecessary eradication therapy.
No takes yet. Share an insight, caveat, or question.
Wakamatsu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: